HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
Remember me:

New Zealand: PEB raises NZ$12.3 million capital

New Zealand-based cancer diagnostics company, Pacific Edge (PEB) has completed its NZ$21.3 million (US$15.1 million) underwritten 1-for-6 rights offer.

It was selling 66.6 million shares at NZ$0.32 per share which is a 26.6% discount to the theoretical ex-rights price of NZ$0.44 per share. Almost three-quarters were taken up. And on Friday, the shortfall bookbuild component was completed at the same price with support from both institutional and other eligible shareholders.

The new shares taken up under the offer are expected to be allotted and commence trading on the NZX Main Board on 15 November.

“We are pleased to have raised the full NZ$21.3 million to help fund our continued growth as we target getting Pacific Edge to a cashflow breakeven position as soon as possible,” said chairman Chris Gallaher.

Net proceeds will be used to provide funding for PEB’s continued growth, particularly in the US, while it targets getting to a cashflow breakeven position as soon as possible. The company said that it anticipates reaching a cashflow breakeven position in the financial year ending March 2019. The company’s 2017 losses grew to NZ$21 million.

The offer was fully underwritten by First NZ Capital Securities.

Posted on: 13/11/2017 UTC+08:00


Paragon Care, a leading distributor and manufacturer supplying medical equipment to hospitals, is to raise A$69.8 million (US$54.6 million) in a fully underwritten offer on the ASX.
Parkway Life REIT, which is owned by IHH Healthcare, is to acquire Konosu Nursing Home Kyoseien, a nursing rehabilitation facility in Greater Tokyo, under a sale-and-leaseback agreement with Iryouhoujin Shadan Kouaikai for ¥1.5 billion (US$13.7 million).
New Zealand-based cancer diagnostics company Pacific Edge (PEB) has entered into an agreement with MediNcrease Health Plans, a US national provider network, to make its bladder cancer diagnostic test available.
Beijing-based paediatric centre Dr Cuiyutao Healthcare has raised Series C plus funding led by New Oriental Education & Technology Group. The size of the funding has not been disclosed, but is understood to be in the millions of US dollars.
Kelantan-based Ain Medicare, which manufactures both blood and renal medical devices as well as pharmaceutical products, has raised M$20 million (US$5.1 million) in a strategic investment from Malaysian government investment company A-BIO.
Anthea Muir has been named chief executive of Australian cosmetic clinic chain Laser Clinics Australia with Paul McClintock as chairman. Muir comes from Luxottica Group while McClintock is best known as the former chairman of Medibank Private.
Harmonicare Medical, the largest private obstetrics and gynaecology specialty hospital group in China, has increased its loan to help the Rmb160 million (US$25.3 million) construction of Wuxi Harmonicare, a new obstetrics and gynaecology hospital in Wuxi, Jiangsu Province.
Higher sales have given a boost to third quarter results at medical rubber glove manufacturer Hartalega Holdings.


A new paper from KPMG looks at the disconnect between consumer expectations and the current healthcare experience of patients in Australia.
Gan Kim Yong, Singapore’s minister for health, explains why integrated care is important in the context of an ageing population.
Not having featured before 2015, Chinese investment in Australia’s healthcare sector has surged over the past three years. It has reached A$5.5 billion (US$4.5 billion) across 16 completed deals, according to a new report from KPMG and The University of Sydney Business School.
Michael Griffiths, regional director of healthcare at specialist insurance brokers Howden, explains how insurance is an answer to the region’s healthcare crisis.
Nomaan Mirza, principal equity specialist at the International Finance Corporation, looks at healthcare equity opportunities in emerging markets.
The healthcare industry in Asia-Pacific is expected to grow at 11.1% in 2018, representing one of the fastest growing regions in the world, as the global healthcare economy averages a 4.8% annual growth rate.
Technologist, business leader, and philanthropist Bill Gates explains why global health needs the private sector.
Mitch Beaumont, Prashanth Prasad, Ulrica Sehlstedt and Mandeep Dhillon from international management consultants Arthur D. Little explain how medical technology companies can manage going digital.
my images


Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices